ArriVent BioPharma (AVBP) Current Assets (2022 - 2026)
ArriVent BioPharma's Current Assets came in at $394.17 million for Q2 2026, up 57.6% from $250.15 million a year earlier and up 13.0% from the prior quarter.
Powered by 
Analysis
ArriVent BioPharma (AVBP) Current Assets (2022 - 2026) Analysis & Trends
At the end of FY2025, ArriVent BioPharma's Current Assets was $332.9 million, up 46.7% from FY2024.
- Going back by year, Current Assets was $226.98 million in FY2024 (+41.9%) and $159.97 million in FY2023.
- The Q2 2026 figure represents the highest quarterly Current Assets in data going back to Q4 2023.
- Year-over-year, Current Assets has increased for four consecutive quarters, with growth averaging 25.9% over the last seven quarters.
- Business Quant data shows AVBP's Current Assets at $348.7 million (Q1 2026), $332.9 million (Q4 2025) and $321.22 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 65.26 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 56.35 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 37.48 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 38.94 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 31.45 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 34.36 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 16.55 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 45.01 Bn |
| 10 | ArriVent BioPharma | 690.85 Mn | -714.69 Mn | - | 416.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 416.62 Mn |
| Jun 30, 2026 | 394.17 Mn |
| Mar 31, 2026 | 348.70 Mn |
| Dec 31, 2025 | 332.90 Mn |
| Sep 30, 2025 | 321.22 Mn |
| Jun 30, 2025 | 250.15 Mn |
| Mar 31, 2025 | 185.79 Mn |
| Dec 31, 2024 | 226.98 Mn |
| Sep 30, 2024 | 292.40 Mn |
| Jun 30, 2024 | 308.51 Mn |
| Mar 31, 2024 | 327.48 Mn |
| Dec 31, 2023 | 159.97 Mn |
| Dec 31, 2022 | 182.62 Mn |
API Access
ArriVent BioPharma Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=AVBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "AVBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=AVBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();